Walgreens Enhances Clinical Research through Patient Insights
With a legacy spanning over 120 years, Walgreens is not just a pharmacy; it's a steadfast partner for millions of patients across the nation. Recent developments highlight Walgreens' ongoing commitment to elevate patient participation in clinical research. This commitment has materialized with the establishment of the Walgreens Clinical Trials Patient Advisory Board.
The Formation of the Patient Advisory Board
Launched with a focus on community engagement in clinical trials, this board began its journey in June 2022, reaching out to over 7 million patients to enhance awareness and recruitment in sponsor-led research. As Walgreens continues to expand its efforts, the insights from the Patient Advisory Board will play a crucial role in shaping the future of clinical research.
Understanding Patient Needs and Experiences
Comprising 10 dedicated patient experts, the inaugural Patient Advisory Board brings together individuals with diverse experiences in healthcare. Their unique perspectives are essential in improving recruitment and retention in clinical trials, particularly within communities that have often faced barriers to participation. Ramita Tandon, the chief biopharma services officer, is at the helm of this initiative, emphasizing Walgreens' dedication to making clinical trials more inclusive.
Addressing the Challenges of Clinical Trial Participation
Statistics reveal a concerning trend in clinical trial participation; only 5% of the U.S. population currently engages in these trials, with a staggering 80% failing to meet their enrollment targets. Tandon articulates the urgency in correcting this trend, mentioning that input from the advisory board will transform how Walgreens conducts its clinical trials, ensuring that they are better tailored to serve the needs of all patients involved.
The Importance of Patient Perspectives
With regulators increasingly emphasizing the role of patient perspectives in drug development, now is the perfect time to engage directly with those impacted by clinical research. The life experiences of advisory board members are powerful tools for ongoing improvement in clinical trial practices. Their feedback will be instrumental in designing trials that are more effective and accessible for diverse populations.
The Commitment of the Advisory Board
Members of the Walgreens Clinical Trials Patient Advisory Board are poised to make a significant impact over their two-year tenure. They will provide ongoing advice, innovative thinking, and specialized expertise, helping to guide Walgreens' efforts in clinical trials. This collaborative approach promises to enhance the quality and efficacy of clinical research at Walgreens.
About Walgreens
Founded in 1901, Walgreens operates approximately 8,500 stores across the United States and Puerto Rico, serving nearly 9 million customers daily. The company boasts a workforce of about 220,000 employees, including a substantial number of healthcare professionals dedicated to providing top-notch pharmacy and health services.
As the flagship brand of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), Walgreens is recognized for its critical role in healthcare, offering convenient access to pharmacy services and patient care. Walgreens Specialty Pharmacy continues to deliver essential services to patients dealing with complex health conditions, reinforcing its position as a leader in integrated healthcare.
Frequently Asked Questions
What is the purpose of the Walgreens Clinical Trials Patient Advisory Board?
The board aims to enhance engagement, recruitment, and representation of patients in clinical trials, ensuring their voices are heard in the research process.
How long will the advisory board serve?
The members of the Patient Advisory Board will serve a two-year term, contributing their insights and expertise throughout this period.
Why is patient representation important in clinical trials?
Patient representation is crucial for developing trials that reflect the needs and experiences of diverse populations, ultimately improving drug efficacy and safety.
What challenges do clinical trials currently face?
Common challenges include low participation rates, with only 5% of the U.S. population involved, and many trials failing to meet enrollment goals.
How can patients get involved in clinical trials?
Patients can express interest in participating in clinical trials through healthcare providers or by engaging with organizations such as Walgreens that offer research opportunities.
